Does OSIMERTINIB Cause Leukopenia? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Leukopenia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.2% of all adverse event reports for OSIMERTINIB.
59
Reports of Leukopenia with OSIMERTINIB
0.2%
of all OSIMERTINIB reports
5
Deaths
14
Hospitalizations
How Dangerous Is Leukopenia From OSIMERTINIB?
Of the 59 reports, 5 (8.5%) resulted in death, 14 (23.7%) required hospitalization, and 5 (8.5%) were considered life-threatening.
Is Leukopenia Listed in the Official Label?
Yes, Leukopenia is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Leukopenia?
METHOTREXATE (2,694)
CYCLOPHOSPHAMIDE (2,482)
RITUXIMAB (2,191)
CLOZAPINE (2,036)
PREDNISONE (1,725)
DOXORUBICIN (1,696)
PACLITAXEL (1,649)
CARBOPLATIN (1,624)
DEXAMETHASONE (1,542)
MYCOPHENOLATE MOFETIL (1,491)
Which OSIMERTINIB Alternatives Have Lower Leukopenia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN